BRUSSELS (Reuters) - Belgian biotech firm MDxHealth has signed a deal with U.S. healthcare network Stratose, which will give its prostate cancer testing product access to one of the largest networks in the United States.
via Reuters: Health News Read More Here..
No comments:
Post a Comment